Old Web
English
Sign In
Acemap
>
authorDetail
>
Fabienne Edema-Hildebrand
Fabienne Edema-Hildebrand
Royal North Shore Hospital
Medicine
Mitochondrial disease
FGF21
Neuromuscular disease
Biomarker (medicine)
4
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Patient Care Standards for Primary Mitochondrial Disease in Australia. An Australian adaptation of the Mitochondrial Medicine Society recommendations.
2021
Internal Medicine Journal
Carolyn M. Sue
Shanti Balasubramaniam
Drago Bratkovic
Catherine Bonifant
John Christodoulou
David Coman
Karen Crawley
Fabienne Edema-Hildebrand
Carolyn Ellaway
Roula Ghaoui
Lisa S. Kearns
Joy Lee
Christina Liang
David A. Mackey
Sean Murray
Merrilee Needham
Rocio Ruis
Jacqui Russell
Dominic Thyagarajan
Christine Wools
Show All
Source
Cite
Save
Citations (0)
080 The diagnostic journey of mitochondrial disease patients
2021
Laura I Rudaks
Eloise Watson
Michal Lubomski
Fabienne Edema-Hildebrand
Kate Ahmad
Christina Liang
Ryan L. Davis
Carolyn M. Sue
Show All
Source
Cite
Save
Citations (0)
Serum metabolomic profiling for diagnosis of mitochondrial diseases
2017
Journal of Neurology, Neurosurgery, and Psychiatry
Ryan L. Davis
Anthony Dona
Joanna Pakiriah
Christina Liang
Fabienne Edema-Hildebrand
Carolyn M. Sue
Show All
Source
Cite
Save
Citations (0)
Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease
2013
Neurology
Ryan L. Davis
Christina Liang
Fabienne Edema-Hildebrand
Catherine Riley
Merrilee Needham
Carolyn M. Sue
Show All
Source
Cite
Save
Citations (71)
1